We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medicare Has Spent $224 Million on Therapies with Confirmed Lack of Benefit, Study Shows
Medicare Has Spent $224 Million on Therapies with Confirmed Lack of Benefit, Study Shows
In the last 10 months, the FDA evaluated drugs on the market for 10 cancer indications after having granted them accelerated approval (AA) based on surrogate endpoints, and eventually found that the drugs had a confirmed lack of benefit in several indications — but not before Medicare spent $224 million on them from 2017 to 2019.